Overview

Pharmacokinetics of Lidocaine in Healthy Adults

Status:
Completed

Trial end date:
2019-10-09

Target enrollment:

Participant gender:

Summary

The study to be performed will utilize already FDA-approved marketed products in healthy adults for the purpose to generate data for establishing rate of drug delivery of Lidoderm® topical patch (manufactured by Endo Pharmaceuticals) and the lidocaine 5% patch (manufactured by Mylan Pharmaceuticals) in healthy adults, and to ensure the safety of individuals utilizing these types of products.

Phase:

Phase 4

Details

Lead Sponsor:

Nicole K Brogden
University of Iowa

Collaborator:

Long Island University

Treatments:

Lidocaine